Gilead Sciences, Inc. GILD announces its next round of earnings this Thursday, Oct. 25. Here's Benzinga's advanced look at Gilead's Q3 earnings report.
Earnings and Revenue
Wall Street expects EPS of $1.63 and sales around $5.38 billion.
Gilead reported a per-share profit of $2.27 when it published results during the same quarter last year. Sales in that period totaled $6.51 billion. If the company were to report inline earnings when it publishes results Thursday, earnings would be down 28.19 percent. Revenue would be down 17.38 percent on a year-over-year basis. Here's how the company's reported EPS has stacked up against analyst estimates in the past:
Quarter | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 |
EPS Estimate | 1.56 | 1.64 | 1.67 | 2.12 |
EPS Actual | 1.91 | 1.48 | 1.78 | 2.27 |
Stock Performance
Over the past 52-week period, shares of Gilead have declined 15.17 percent. Analyst estimates are adjusted lower for EPS and revenues over the past 90 days. The average rating by analysts on Gilead stock is a Neutral. The validity of this rating has maintained conviction over the past 90 days.
Conference Call
Gilead's Q3 is scheduled to hold a conference call at 4:30 p.m. ET and it can be accessed here: https://edge.media-server.com/m6/p/nwdg2a73
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.